Keybanc Maintains Overweight on Alignment Healthcare, Lowers Price Target to $12
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Keybanc analyst Matthew Gillmor maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $28 to $12.
Keybanc analyst Matthew Gillmor maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $28 to $12.